Development of a Potent Inhibitor of the Plasmodium Proteasome with Reduced Mammalian Toxicity-Reference-Cited by-同舟云学术

Development of a Potent Inhibitor of the Plasmodium Proteasome with Reduced Mammalian Toxicity

Published:2017-07-25 Issue:15 Volume:60 Page:6721-6732
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

LaMonte Gregory M.¹,Almaliti Jehad²³,Bibo-Verdugo Betsaida⁴,Keller Lena²,Zou Bing Yu¹,Yang Jennifer¹,Antonova-Koch Yevgeniya¹,Orjuela-Sanchez Pamela¹,Boyle Colleen A.¹,Vigil Edgar¹,Wang Lawrence¹,Goldgof Gregory M.¹,Gerwick Lena⁴,O’Donoghue Anthony J.⁴,Winzeler Elizabeth A.¹^ORCID,Gerwick William H.⁴²^ORCID,Ottilie Sabine¹^ORCID

Affiliation:

1. Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, California 92093, United States

2. Scripps Institution of Oceanography, University of California, San Diego, La Jolla, California 92093, United States

3. Department of Pharmaceutical Sciences, Faculty of Pharmacy, The University of Jordan, Amman 11942, Jordan

4. Skaggs School of Pharmacy and Pharmaceutical Sciences, Faculty of Pharmacy, and School of Medicine, University of California, San Diego, La Jolla, California 92093, United States

Funder

Skaggs School of Pharmacy and Pharmaceutical Sciences

National Institute of Allergy and Infectious Diseases

Deutsche Forschungsgemeinschaft

Bill and Melinda Gates Foundation

U.S. Department of Defense

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link